The Full Wiki

More info on Aflibercept

Aflibercept: Wikis

Advertisements
  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Aflibercept
Systematic (IUPAC) name
Unable to be assigned
Identifiers
CAS number  ?
ATC code none
PubChem  ?
Chemical data
Formula C 4318H6788N1164O1304S32  
Mol. mass 96.90 kDa
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

Aflibercept is a fusion protein under development for the treatment of cancer.

It functions as an inhibitor of vascular endothelial growth factor.[1][2]

Aflibercept is being co-developed by Sanofi-Aventis and Regeneron Pharmaceuticals. As of 2008, it is currently in phase III clinical trials.

References

Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message